VERA
NASDAQ HealthcareVera Therapeutics, Inc. - Class A Common Stock
Biotechnology
📊 Market Data
| Price | $41.17 |
|---|---|
| Volume | 1,215,155 |
| Market Cap | 2.94B |
| Beta | 1.170 |
| RSI (14-Day) | 47.2 |
| 200-Day MA | $32.11 |
| 50-Day MA | $44.25 |
| 52-Week High | $56.05 |
| 52-Week Low | $18.53 |
| Forward P/E | -13.88 |
| Price / Book | 4.85 |
🎯 Investment Strategy Scores
How VERA scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
21/100
High dividend yield + low volatility
🚀 Moon Shot
51/100
High growth potential (high beta + oversold)
🔪 Falling Knife
17/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
67/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
49/100
Large-cap, institutional-quality stocks
Find VERA in your text
Paste any text on the homepage — the tool will extract VERA and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.